L A Stone - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

L A Stone

Showing results (41-50 of 46) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 46 results.

Neurology|September 26, 1997

Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measureL A Stone, J A Frank, P S Albert, et al.

Neurology|October 1, 1995

Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosisL A Stone, P S Albert, M E Smith, et al.

Annals of Neurology|May 1, 1997

Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1bP A Calabresi, L R Tranquill, J M Dambrosia, et al.

Annals of Neurology|May 1, 1993

Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesionsM E Smith, L A Stone, P S Albert, et al.

Neurology|June 9, 2004

Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effectsP W O'Connor, A Goodman, A J Willmer-Hulme, et al.

Annals of Neurology|May 1, 1994

Correlation of clinical features and findings on cranial magnetic resonance imaging with urinary myelin basic protein-like material in patients with multiple sclerosisJ N Whitaker, P H Williams, B A Layton, et al.

Pageof 5

Search research articles

Showing results (41-50 of 46) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 46 results.

Neurology|September 26, 1997

Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measureL A Stone, J A Frank, P S Albert, et al.

Neurology|October 1, 1995

Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosisL A Stone, P S Albert, M E Smith, et al.

Annals of Neurology|May 1, 1997

Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1bP A Calabresi, L R Tranquill, J M Dambrosia, et al.

Annals of Neurology|May 1, 1993

Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesionsM E Smith, L A Stone, P S Albert, et al.

Neurology|June 9, 2004

Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effectsP W O'Connor, A Goodman, A J Willmer-Hulme, et al.

Annals of Neurology|May 1, 1994

Correlation of clinical features and findings on cranial magnetic resonance imaging with urinary myelin basic protein-like material in patients with multiple sclerosisJ N Whitaker, P H Williams, B A Layton, et al.

Pageof 5